Medco's New Idea: PGx Program for Generics to Dispense 'Smarter' Treatments and Increase Savings
October 07, 2009
Medco's New Idea: PGx Program for Generics to Dispense 'Smarter' Treatments and Increase Savings
Under the Genetics for Generics program, Medco will aim to make "generic drugs work better with genetics" and "help the system afford innovative products that address true unmet need," according to Chief Medical Officer Robert Epstein.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People in the News: Robert Epstein, Erin O'Shea
December 5, 2012 / Pharmacogenomics Reporter - Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
May 9, 2012 / Pharmacogenomics Reporter - Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
July 27, 2011 / Pharmacogenomics Reporter - Medco Taps MolecularMD to Provide BCR-ABL Testing for TKI Inhibitors in CML Patients
June 8, 2011 / Pharmacogenomics Reporter - Medco to Compare Effient vs. PGx-Guided Plavix in Heart Patients on Prevacid
July 28, 2010 / Pharmacogenomics Reporter